Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

ONCTERNAL THERAPEUTICS, INC.

(ONCT)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about ONCTERNAL THERAPEUTICS, INC.
11/15ONCTERNAL THERAPEUTICS : ONCT-216 - Ravin 2021 CTOS Oral Presentation Slides
PU
11/15Oncternal Therapeutics Presented Updated Interim Phase 1/2 Clinical Trial Data for ONCT..
AQ
11/15Oncternal Therapeutics, Inc. Presents Updated Interim Phase 1/2 Clinical Trial Data for..
CI
11/09Oncternal Therapeutics to Present at the 12th Annual Jefferies London Healthcare Confer..
GL
11/04ONCTERNAL THERAPEUTICS : Q3 Earnings Snapshot
AQ
11/04Oncternal Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Mo..
CI
11/04Corporate Presentation, November 2021
PU
11/04Oncternal Provides Business Update and Announces Third Quarter 2021 Financial Results
AQ
11/04Oncternal Provides Business Update and Announces Third Quarter 2021 Financial Results -..
PU
11/03Oncternal Therapeutics Joins Karolinska Institutet's NextGenNK Competence Center for th..
AQ
11/03Oncternal Therapeutics Joins Karolinska Institutet?s NextGenNK Competence Center for th..
CI
11/02Oncternal Therapeutics Announces Formation of Cell Therapy Scientific Advisory Board
GL
11/02Oncternal Therapeutics, Inc. Announces Board Appointments
CI
11/01Oncternal Therapeutics Reports Granting of Inducement Award Under Nasdaq Listing Rule 5..
GL
10/29Oncternal Therapeutics to Provide Business Update and Report Third Quarter 2021 Financi..
GL
More most relevant news
All news about ONCTERNAL THERAPEUTICS, INC.
11/15ONCTERNAL THERAPEUTICS : ONCT-216 - Ravin 2021 CTOS Oral Presentation Slides
PU
11/15Oncternal Therapeutics Presented Updated Interim Phase 1/2 Clinical Trial Data for ONCT..
AQ
11/15Oncternal Therapeutics, Inc. Presents Updated Interim Phase 1/2 Clinical Trial Data for..
CI
11/09Oncternal Therapeutics to Present at the 12th Annual Jefferies London Healthcare Confer..
GL
11/04ONCTERNAL THERAPEUTICS : Q3 Earnings Snapshot
AQ
11/04ONCTERNAL THERAPEUTICS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITI..
AQ
11/04Oncternal Therapeutics, Inc. Reports Earnings Results for the Third Quarter and Nine Mo..
CI
11/04Corporate Presentation, November 2021
PU
11/04Oncternal Provides Business Update and Announces Third Quarter 2021 Financial Results
AQ
11/04Oncternal Provides Business Update and Announces Third Quarter 2021 Financial Results -..
PU
More news
News in other languages on ONCTERNAL THERAPEUTICS, INC.
10/05Le médicament potentiel d'Oncternal Therapeutics contre le cancer de la prostate montre..
09/20Oncternal et Celularity collaborent dans le domaine des thérapies cellulaires ciblées d..
More news
Analyst Recommendations on ONCTERNAL THERAPEUTICS, INC.
04/16ONCTERNAL THERAPEUTICS : Oppenheimer Adjusts Oncternal Therapeutics PT to $16 From $14, Ma..
MT
04/07ONCTERNAL THERAPEUTICS : Oppenheimer Starts Oncternal Therapeutics at Outperform with $14 ..
MT
03/30ONCTERNAL THERAPEUTICS : Brookline Capital Initiates Coverage on Oncternal Therapeutics Wi..
MT
02/23ONCTERNAL THERAPEUTICS : Northland Starts Oncternal Therapeutics at Outperform With $21 Pr..
MT
More recommendations
Press releases
11/15ONCTERNAL THERAPEUTICS : ONCT-216 - Ravin 2021 CTOS Oral Presentation Slides
PU
11/15Oncternal Therapeutics Presented Updated Interim Phase 1/2 Clinical Trial Data for ONCT..
AQ
11/09Oncternal Therapeutics to Present at the 12th Annual Jefferies London Healthcare Confer..
GL
11/04ONCTERNAL THERAPEUTICS : Q3 Earnings Snapshot
AQ
11/04ONCTERNAL THERAPEUTICS, INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITI..
AQ
More press releases
Upcoming event on ONCTERNAL THERAPEUTICS, INC.
03/10/22